Prior authorization automation that survives payer audits

The problem

A prior authorization request sits in a queue for three days. A nurse assembles the packet manually: the order, the clinical rationale, the labs, the previous failed therapy, the guideline citation. Half the requests are denied as "not medically necessary" because the packet missed a specific payer requirement the nurse could not have known without reading fifty pages of payer policy. The patient's treatment slips. The practice loses revenue. The nurse burns out.

Why the usual approach breaks

Generic automation tools fill templates. They do not read payer policy. They do not know that United requires a documented trial of generic methotrexate before approving adalimumab for rheumatoid arthritis, while Anthem requires a specific disease-activity score. The automation produces a well-formatted packet that fails for a reason the template could not anticipate.

Standalone AI drafters hallucinate citations. An approval won on a fabricated reference becomes a clawback the following quarter. The practice would be better off submitting a blank form.

How AI for BA closes the gap

AI for BA reads payer policy as structured knowledge, not template glue. For each payer, each plan, and each therapy, the system knows the specific clinical criteria, documentation requirements, and prior-therapy trials the payer requires. When a clinician orders a therapy, the assistant checks the patient's chart against the relevant payer policy and flags missing documentation before the request is submitted.

Every citation in the generated packet is verifiable: the policy reference is a live link to the payer's current published policy, the clinical citation is a specific chart element with a timestamp, the prior-therapy trial is documented against encounter IDs. If the payer updates the policy, the assistant flags the patients whose requests would be affected before the next batch goes out.

Implementation pattern

The system starts with the three highest-volume therapies that drive the most denials. The baseline is measured in days-to-decision, denial rate, and appeal overturn rate. As the payer-policy knowledge base grows, the scope expands. The nurses do not disappear, they move up-stack to the complex cases the assistant flags for human review.

Every denial outcome flows back into the evaluation set. When a class of denial starts trending up, the team knows within a week, not a quarter.

Next step

An architecture review takes your three most-painful prior-auth therapies, your payer mix, and your current cycle-time baseline, and produces an eight-week plan your revenue cycle and clinical informatics teams can execute against.

Book an architecture review →